SMAS: a Prospective Study in a Single Institution
Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution
1 other identifier
interventional
39
1 country
1
Brief Summary
Superior Mesenteric Artery Syndrome (SMAS) is a rare cause of duodenal obstruction, that should be suspected in cases of chronic, refractory upper digestive symptoms. Between 2008 and 2016, 39 consecutive patients with chronic gastrointestinal symptoms and a diagnosis of SMAS were prospectively included in the study, in order to describe their demographic, clinical and outcome features. All patients underwent duodenojejunostomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 18, 2017
CompletedFirst Posted
Study publicly available on registry
January 31, 2018
CompletedJanuary 31, 2018
January 1, 2018
7.6 years
December 18, 2017
January 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Symptom score
Severity (0-6) + frequency (0-5) x 5 symptoms (abd pain, nausea, vomiting, reflux, bloating)
47 months (IQR 34-72)
BMI
Body mass index
47 months (IQR 34-72)
Need for medical treatment
PPIs, prokinetic drugs
47 months (IQR 34-72)
Study Arms (1)
SMAS patients
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- severe and frequent upper digestive symptoms (occurring at least once a week), associated to poor quality of life and refractory response to medical treatment;
- a condition of underweight (BMI \<18.5 kg/m2) associated with difficulty eating;
- severe complications of SMAS (e.g. gastric perforation, acute pancreatitis, aspiration pneumonia);
- suggestive findings of SMAS at barium swallow;
- diagnostic aortomesenteric angle and distance at CT/MR angiography.
You may not qualify if:
- inability to provide the informed consent;
- malignancies;
- bowel motility disorders;
- severe psychiatric illness;
- pregnancy;
- impossibility to perform the required diagnostic workup.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Surgery Unit
Padua, PD, 35128, Italy
Related Publications (1)
Ganss A, Rampado S, Savarino E, Bardini R. Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution. J Gastrointest Surg. 2019 May;23(5):997-1005. doi: 10.1007/s11605-018-3984-6. Epub 2018 Oct 5.
PMID: 30291587DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angelica Ganss, M.D.
General Surgery Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 18, 2017
First Posted
January 31, 2018
Study Start
October 1, 2008
Primary Completion
May 1, 2016
Study Completion
February 1, 2017
Last Updated
January 31, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share